Recombinant human DNase in management of lobar atelectasis due to retained secretions.
- 1 December 1995
- Vol. 50 (12) , 1319-1323
- https://doi.org/10.1136/thx.50.12.1319
Abstract
Recombinant human deoxyribonuclease (rhDNase) is an agent which reduces the viscoelasticity of purulent sputum. Two cases are reported in which rhDNase was utilised for the management of lobar atelectasis due to retained purulent secretions.Keywords
This publication has 8 references indexed in Scilit:
- Effect of Aerosolized Recombinant Human DNase on Exacerbations of Respiratory Symptoms and on Pulmonary Function in Patients with Cystic FibrosisNew England Journal of Medicine, 1994
- Lobar atelectasis in cystic fibrosis and treatment with recombinant human DNase IRespiratory Medicine, 1994
- A Preliminary Study of Aerosolized Recombinant Human Deoxyribonuclease I in the Treatment of Cystic FibrosisNew England Journal of Medicine, 1992
- Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum.Proceedings of the National Academy of Sciences, 1990
- Effects of Periodic Positive Airway Pressure by Mask on Postoperative Pulmonary FunctionChest, 1986
- ACUTE LOBAR ATELECTASIS - PROSPECTIVE COMPARISON OF FIBEROPTIC BRONCHOSCOPY AND RESPIRATORY THERAPYPublished by Elsevier ,1979
- Studies on pulmonary secretions. 3. The nucleic acids in whole pulmonary secretions from patients with cystic fibrosis, bronchiectasis, and laryngectomy.Published by Elsevier ,1969
- LIQUEFACTION OF VISCOUS PURULENT EXUDATES BY DEOXYRIBONUCLEASEThe Lancet, 1950